Pioglitazone: risk of bladder cancer

The MHRA has just posted a safety update that the use of pioglitazone is associated with a small increased risk of bladder cancer. Healthcare professionals should be aware of new warnings and precautions for use in at-risk patients. The advice for healthcare professionals include: Patients with active bladder cancer or with a history of bladder […]